Galactosylation of serum immunoglobulin G in myasthenia gravis with different autoantibodies.

MuSK myasthenia gravis Myasthenia gravis acetylcholine receptor immunoelectrophoresis immunoglobulin G lectins

Journal

Scandinavian journal of clinical and laboratory investigation
ISSN: 1502-7686
Titre abrégé: Scand J Clin Lab Invest
Pays: England
ID NLM: 0404375

Informations de publication

Date de publication:
09 2023
Historique:
medline: 4 9 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

Myasthenia gravis (MG) is a disease with impaired transmission at the neuromuscular junction, characterised by weakness and fatigability of skeletal muscles. In acquired autoimmune MG, antibodies against acetylcholine receptor (AChRAb) or muscle-specific tyrosine kinase (MuSKAb) are present. There is not much data about immunoglobulin G (IgG) galactosylation in MG, and none based on interactions with lectins. This study aims to examine IgG galactosylation in two types of myasthenia, using affinity immunoelectrophoresis with lectin concanavalin A (Con A). Affinity of Con A-IgG interaction, expressed as retardation coefficient (R), indicated the presence of degalactosylated IgG. The average

Identifiants

pubmed: 37428449
doi: 10.1080/00365513.2023.2230550
doi:

Substances chimiques

Autoantibodies 0
Immunoglobulin G 0
Receptors, Cholinergic 0
Protein-Tyrosine Kinases EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

348-355

Auteurs

Ljiljana Hajdukovic (L)

Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Belgrade, Serbia.

Aleksa Palibrk (A)

Faculty of Medicine, Neurology Clinic, University of Belgrade, University Clinical Center of Serbia, Belgrade, Serbia.

Stojan Peric (S)

Faculty of Medicine, Neurology Clinic, University of Belgrade, University Clinical Center of Serbia, Belgrade, Serbia.

Ivana Basta (I)

Faculty of Medicine, Neurology Clinic, University of Belgrade, University Clinical Center of Serbia, Belgrade, Serbia.

Rajna Minic (R)

Institute for Medical Research, Group for Immunology, University of Belgrade, National Institute of Republic of Serbia, Belgrade, Serbia.

Miroslava Jankovic (M)

Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Belgrade, Serbia.

Dragana Lavrnic (D)

Faculty of Medicine, Neurology Clinic, University of Belgrade, University Clinical Center of Serbia, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH